RAT coronavirus infection of primary RAT alveolar epithelial cells

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 351-356

  Miura, Tanya A ^a   Wang, Jieru ^b   Mason, Robert J ^b   Holmes, Kathryn V ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934436971     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_62     Document Type: Conference Paper

References (22)

1. L. van der Hoek, K. Pyrc, M. F. Jebbink, W. Vermeulen-Oost, R. J. Berkhout, K. C. Wolthers, P. M. Wertheim-van Dillen, J. Kaandorp, J. Spaargaren, and B. Berkhout, Identification of a new human coronavirus, Nat. Med. 10, 368-373 (2004).
2. R. A. Fouchier, N. G. Hartwig, T. M. Bestebroer, B. Niemeyer, J. C. de Jong, J. H. Simon, and A. D. Osterhaus, A previously undescribed coronavirus associated with respiratory disease in humans, Proc. Natl. Acad. Sci. USA 101, 6212-6216 (2004).
3. P. C. Woo, S. K. Lau, C. M. Chu, K. H. Chan, H. W. Tsoi, Y. Huang, B. H. Wong, R. W. Poon, J. J. Cai, W. K. Luk, et al., Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia, J. Virol. 79, 884-895 (2005).
4. D. O Toole, I. Brown, A. Bridges, and S. F. Cartwright, Pathogenicity of experimental infection with pneumotropic porcine coronavirus, Res. Vet. Sci. 47, 23-29 (1989).
5. J. Storz, X. Lin, C. W. Purdy, V. N. Chouljenko, K. G. Kousoulas, F. M. Enright, W. C. Gilmore, R. E. Briggs, and R. W. Loan, Coronavirus and Pasteurella infections in bovine shipping fever pneumonia and Evans criteria for causation, J. Clin. Microbiol. 38, 3291-3298 (2000).
6. K. Erles, C. Toomey, H. W. Brooks, and J. Brownlie, Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease, Virology 310, 216-223 (2003).
7. P. N. Bhatt, D. H. Percy, and A. M. Jonas, Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group, J. Infect. Dis. 126, 123-130 (1972).
8. Y. L. Lai, R. O. Jacoby, P. N. Bhatt, and A. M. Jonas, Keratoconjunctivitis associated with sialodacryoadenitis in rats, Invest. Ophthalmol. 15, 538-541 (1976).
9. K. Utsumi, Y. Yokota, T. Ishikawa, K. Ohnishi, and K. Fujiwara, in: Coronaviruses and Their Diseases, edited by D. Cavanagh and T. D. K. Brown, (Plenum Press, New York, 1990), pp. 525-532.
10. Z. W. Wojcinski and D. H. Percy, Sialodacryoadenitis virus-associated lesions in the lower respiratory tract of rats, Vet. Pathol. 23, 278-286 (1986).
11. J. C. Parker, S. S. Cross, and W. P. Rowe, Rat coronavirus (RCV): a prevalent, naturally occurring pneumotropic virus of rats, Arch. Gesamte. Virusforsch. 31, 293-302 (1970).
12. P. N. Bhatt and R. O. Jacoby, Experimental infection of adult axenic rats with Parker's rat coronavirus, Arch. Virol. 54, 345-352 (1977).
13. S. Gagneten, C. A. Scanga, G. S. Dveksler, N. Beauchemin, D. Percy, and K. V. Holmes, Attachment glycoproteins and receptor specificity of rat coronaviruses, Lab. Anim. Sci. 46, 159-166 (1996).
14. L. G. Dobbs and R. J. Mason, Pulmonary alveolar type II cells isolated from rats. Release of phosphatidylcholine in response to beta-adrenergic stimulation, J. Clin. Invest. 63, 378-387 (1979).
15. R. J. Mason, M. C. Lewis, K. E. Edeen, K. McCormick-Shannon, L. D. Nielsen, and J. M. Shannon, Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro, Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L249-258 (2002).
16. T. M. Gallagher and M. J. Buchmeier, Coronavirus spike proteins in viral entry and pathogenesis, Virology 279, 371-374 (2001).
17. S. T. Hingley, I. Leparc-Goffart, S. H. Seo, J. C. Tsai, and S. R. Weiss, The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion, J. Neurovirol. 8, 400-410 (2002).
18. I. Hamming, W. Timens, M. L. Bulthuis, A. T. Lely, G. J. Navis, and H. van Goor, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J. Pathol. 203, 631-637 (2004).
19. S. A. Jeffers, S. M. Tusell, L. Gillim-Ross, E. M. Hemmila, J. E. Achenbach, G. J. Babcock, W. D. Thomas, Jr., L. B. Thackray, M. D. Young, R. J. Mason, et al., CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proc. Natl. Acad. Sci. USA 101, 15748-15753 (2004).
20. K. F. To, J. H. Tong, P. K. Chan, F. W. Au, S. S. Chim, K. C. Chan, J. L. Cheung, E. Y. Liu, G. M. Tse, A. W. Lo, et al., Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases, J. Pathol. 202, 157-163 (2004).
21. K. F. To and A. W. Lo, Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2), J. Pathol. 203, 740-743 (2004).
22. B. L. Haagmans, T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K. H. Chan, et al., Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat. Med. 10, 290-293 (2004).